Accolade, Inc. (ACCD)
- Previous Close
9.35 - Open
9.33 - Bid 9.38 x 600
- Ask 9.43 x 300
- Day's Range
9.13 - 9.47 - 52 Week Range
6.33 - 17.00 - Volume
564,266 - Avg. Volume
607,100 - Market Cap (intraday)
727.631M - Beta (5Y Monthly) 2.08
- PE Ratio (TTM)
-- - EPS (TTM)
-1.62 - Earnings Date Apr 25, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
14.80
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
www.accolade.com2,370
Full Time Employees
February 28
Fiscal Year Ends
Sector
Industry
Recent News: ACCD
Performance Overview: ACCD
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACCD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACCD
Valuation Measures
Market Cap
727.63M
Enterprise Value
739.31M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.79
Price/Book (mrq)
1.67
Enterprise Value/Revenue
1.90
Enterprise Value/EBITDA
-8.01
Financial Highlights
Profitability and Income Statement
Profit Margin
-31.59%
Return on Assets (ttm)
-9.70%
Return on Equity (ttm)
-26.66%
Revenue (ttm)
388.49M
Net Income Avi to Common (ttm)
-122.73M
Diluted EPS (ttm)
-1.62
Balance Sheet and Cash Flow
Total Cash (mrq)
230.02M
Total Debt/Equity (mrq)
55.60%
Levered Free Cash Flow (ttm)
14.99M